FDA Commissioner Dr. Scott Gottlieb Speaks Out on Need for Generic Competition @accessiblemeds
FDA Commissioner Dr. Scott Gottlieb Speaks Out on Need for Generic Competition  @accessiblemeds
Uploaded July 2017 | Updated November 2026, 3 hours ago
During the week of July 17, 2017, Dr. Scott Gottlieb, Commissioner of the Food and Drug Administration, spoke out about the need to curb anti-competitive practices employed by some brand pharmaceutical companies to keep generic competition off the market. By blocking safe, effective and affordable generic alternatives, these brand companies are able to retain their monopolies past the expiration of their patents and artificially preserve their high prices. The Congress is considering two bills to curb these anti-competitive, anti-patient schemes, the FAST Generics Act in the U.S. House of Representatives and the CREATES Act in the United States Senate. The Association for Accessible Medicines urges swift passage of these important bills to provide patients with relief from the high cost of medicine. Learn more at http://www.stopREMSabuse.com.
FDA Commissioner Dr. Scott Gottlieb Speaks Out on Need for Generic CompetitionAAMs Karin Hessler Provides an Inside Look at the GRx+Biosims 2019 Legal TrackGeneric Drug Savings in the U.S.Mark Hendrickson: Experts, Regulators and Expo at GRx+BiosimsA Conference You Dont Want to Miss — GRx+Biosims 2018Biosimilars Council   Leading on Biosimilars for Americas PatientsSeniors Paying Billions More Than They Should — #DoesntAddUpGeneric Medicines 35th Birthday CelebrationGRx+Biosims 2020 ExpoJoin us at Access! 2026Access! 2019 Day 1 RecapInter Partes Review Process (IPR) - Explainer Video
Association for Accessible Medicines |

FDA Commissioner Dr. Scott Gottlieb Speaks Out on Need for Generic Competition

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER